Rare diseases
Investigational molecules
Locations
Back to Norway16 clinical trials in Fredrikstad, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)Study on the Safety and Effectiveness of Pirtobrutinib for Adults with Immune Thrombocytopenia
NorwayStudy on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers
NorwayStudy on Zoledronic Acid for Patients with Chronic Low Back Pain with Modic Changes
NorwayStudy on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer
NorwayStudy Comparing Avatrombopag and Rituximab for Adults with Immune Thrombocytopenia Not Responding to Corticosteroids
NorwayStudy on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism
NorwayStudy of Tranexamic Acid Applied to Surgical Wounds to Prevent Bleeding Complications After Plastic Surgery in Adult Patients
NorwayStudy on the Effectiveness of Abiraterone, Capivasertib, and Enzalutamide in Patients with Metastatic Prostate Cancer
NorwayStudy Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma
NorwayStudy of diazepam and oxazepam in patients with benzodiazepine and opioid dependence who are receiving opioid agonist therapy
NorwayStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
NorwaySafety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia
NorwayThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on precision cancer medicine for rare and hard-to-treat cancers, including groundbreaking research in metastatic prostate cancer and melanoma treatment approaches.
Research emphasizes personalized treatment strategies and novel drug applications.
Comprehensive research on Immune Thrombocytopenia (ITP) and related blood disorders, evaluating new therapeutic approaches and drug efficacy.
Focus on developing effective treatments for various blood-related conditions.
Studies examining treatment outcomes in schizophrenia patients, with particular attention to cognitive impairment and long-term safety assessments.
Emphasis on improving patient outcomes through targeted interventions.
Research investigating treatments for rheumatoid arthritis and chronic low back pain, including innovative therapeutic monitoring approaches.
Focus on improving quality of life through effective disease management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
